Research Summary
Analyzed using Evidence Intelligence™

Ultrasound therapy improves pain in diabetic neuropathy

Last updated July 11, 2026

Key finding

Postoperative VAS scores were significantly lower than preoperative (P<0.05).

This study investigated the effects of ultrasound-guided stellate ganglion pulsed radiofrequency therapy on painful diabetic peripheral neuropathy in type 2 diabetes patients, finding significant postoperative improvements in pain and quality of life.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study investigated the effects of ultrasound-guided stellate ganglion pulsed radiofrequency therapy on painful diabetic peripheral neuropathy in type 2 diabetes patients, finding significant postoperative improvements in pain and quality of life.

Clinical relevance

Managing painful diabetic peripheral neuropathy is crucial for improving the quality of life in patients with type 2 diabetes. The findings suggest that ultrasound-guided stellate ganglion pulsed radiofrequency therapy may offer a new, effective treatment option, potentially reducing reliance on medications and enhancing patient outcomes.

Keep in mind

Non-randomized design limits the ability to draw causal conclusions. Sample size may restrict generalizability of findings. Lack of long-term follow-up data on treatment effects.

Published in

Journal Reference

Publication details and source links for this paper.

Jiying W, Weisheng X, Qingqing W, et al. Ultrasound-guided stellate ganglion pulsed radiofrequency therapy for painful diabetic peripheral neuropathy in type 2 diabetes mellitus patients. Journal of Pain Research. 2024;17:4521-4531. doi:10.2147/JPR.S497061

Main Effects

Postoperative VAS scores decreased significantly by 3.28 points (P<0.001).

Postoperative SF-MPQ scores decreased significantly by 9.38 points (P<0.001).

Postoperative KPS values increased significantly by 4.36 points (P<0.001).

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion and Depression severity measured by PHQ-9, Neuropathic pain severity, Pain Disability Index (PDI), and 10 more.

Primary intervention

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion

Primary outcomes

  • Depression severity measured by PHQ-9
  • Neuropathic pain severity
  • Pain Disability Index (PDI)

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

13
Evidence pairs
13
Relationships
0
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 50

0

Related topics

13

Evidence pairs

0

Related studies

Why it is useful

  • Contributes to 13 evidence relationships
  • Includes primary outcome data
  • Linked to 0 direct semantic evidence topics

Core evidence

Study findings

The primary outcomes reported in this study.

Depression severity measured by PHQ-9

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Depression severity measured by PHQ-9

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Depression severity measured by PHQ-9

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Neuropathic pain severity

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Neuropathic pain severity

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Neuropathic pain severity

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Pain Disability Index (PDI)

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Pain Disability Index (PDI)

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Pain Disability Index (PDI)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Pain severity measured by Simplified McGill Pain Questionnaire (SF-MPQ)

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Pain severity measured by Simplified McGill Pain Questionnaire (SF-MPQ)

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Pain severity measured by Simplified McGill Pain Questionnaire (SF-MPQ)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Patient-reported Pain Relief

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Patient-reported Pain Relief

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Patient-reported Pain Relief

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Patient-reported relief from chills

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Patient-reported relief from chills

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Patient-reported relief from chills

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Patient-reported relief from numbness

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Patient-reported relief from numbness

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Patient-reported relief from numbness

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Postoperative Rate of Analgesic Use

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Postoperative Rate of Analgesic Use

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Postoperative Rate of Analgesic Use

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Quality of life measured by Karnofsky Performance Status (KPS)

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Quality of life measured by Karnofsky Performance Status (KPS)

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Quality of life measured by Karnofsky Performance Status (KPS)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Significant Pain Relief Rate

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Significant Pain Relief Rate

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Significant Pain Relief Rate

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Sleep Duration at Night

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Sleep Duration at Night

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Sleep Duration at Night

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Toronto Clinical Scoring System (TCSS)

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Toronto Clinical Scoring System (TCSS)

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Toronto Clinical Scoring System (TCSS)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Total Effective Rate of Treatment

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Total Effective Rate of Treatment

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion → Total Effective Rate of Treatment

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

Evidence Suggest

  • VAS scores showed a significant decrease post-treatment, indicating reduced pain.
  • KPS values improved, suggesting enhanced patient performance status.
  • SF-MPQ scores significantly decreased, reflecting lower pain perception.
who this applies

Who this applies to

  • Adults with type 2 diabetes experiencing painful diabetic peripheral neuropathy.
  • Patients seeking alternative pain management strategies.
keep in mind

Keep in Mind

  • Results may not apply to non-diabetic populations.
  • Further research is needed to confirm long-term efficacy.
  • Study findings are based on a single-arm design, limiting comparison.
between the lines

Between the Lines

  • Non-randomized design limits the ability to draw causal conclusions.
  • Sample size may restrict generalizability of findings.
  • Lack of long-term follow-up data on treatment effects.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion and Depression severity measured by PHQ-9, Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion and Quality of life measured by Karnofsky Performance Status (KPS).

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Included in these evidence collections

Curated evidence collections and hubs this study is part of.

Explore more in Evidence Explorer

Jump to pre-filtered views in Evidence Explorer.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion improve depression severity measured by phq-9?

Emerging Evidence

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion appears to improve Depression severity measured by PHQ-9.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Depression severity measured by PHQ-9

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion improve neuropathic pain severity?

Emerging Evidence

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion appears to improve Neuropathic pain severity.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Neuropathic pain severity

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion improve pain disability index (pdi)?

Emerging Evidence

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion appears to improve Pain Disability Index (PDI).

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Pain Disability Index (PDI)

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion improve pain severity measured by simplified mcgill pain questionnaire (sf-mpq)?

Emerging Evidence

Ultrasound-guided pulsed radiofrequency therapy of the stellate ganglion appears to improve Pain severity measured by Simplified McGill Pain Questionnaire (SF-MPQ).

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Pain severity measured by Simplified McGill Pain Questionnaire (SF-MPQ)

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.